Organigram Holdings Inc. EBIT

EBIT of OGI for past 10 years: annual, quarterly and twelve month trailing (TTM) including EBIT growth rates and interactive chart. Earnings before interest and taxes is an indicator of a company's profitability. One can calculate it as revenue minus all expenses, excluding tax and interest. EBIT is also referred to as operating earnings, operating profit, and profit before interest and taxes. It is the amount of profit that a company earns before interest on debt and taxes are paid.

Highlights and Quick Summary

  • EBIT for the quarter ending February 28, 2022 was $-7.04 Million (a -35.57% decrease compared to previous quarter)
  • Year-over-year quarterly EBIT decreased by -27.77%
  • Annual EBIT for 2021 was $-179 Million (a -34.79% decrease from previous year)
  • Annual EBIT for 2020 was $-274 Million (a 163.52% increase from previous year)
  • Annual EBIT for 2019 was $-104 Million (a 338.77% increase from previous year)
  • Twelve month EBIT ending February 28, 2022 was $-46 Million (a -25.72% decrease compared to previous quarter)
  • Twelve month trailing EBIT decreased by -47.97% year-over-year
Trailing EBIT for the last four month:
28 Feb '22 30 Nov '21 31 Aug '21 31 May '21
$-46 Million $-61.9 Million $-72.4 Million $-88.4 Million
Visit stockrow.com/OGI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EBIT of Organigram Holdings Inc.

Most recent EBITof OGI including historical data for past 10 years.

Interactive Chart of EBIT of Organigram Holdings Inc.

Organigram Holdings Inc. EBIT for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-7.04 – – – –
2021 $-10.92 $-18.28 $-9.75 $-22.97 $-178.91
2020 $-21.43 $-34.24 $-71.07 $-3.06 $-274.37
2019 $0.12 $-21.46 $-8.42 $-1.33 $-104.12
2018 – – $35.35 $2.52 $-23.73
2016 – – – – $1.47

Business Profile of Organigram Holdings Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic
© stockrow.com